A groundbreaking study has revealed the power of early detection in the fight against colorectal cancer. This research, conducted by dedicated scientists at Uppsala University and Karolinska Institutet, has brought hope to the medical community and those affected by this common cancer.
The Key to Early Detection
The study, published in Nature Medicine, focused on two screening methods to detect colorectal cancer at its earliest stages. Over 278,000 participants, aged 60, were randomly assigned to one of three groups: a primary colonoscopy, two fecal immunochemical tests (FIT) followed by a colonoscopy if positive, or no intervention (control group).
Early detection is a game-changer in cancer treatment. As Marcus Westerberg, a docent at Uppsala University's Department of Surgical Sciences and the study's corresponding author, explains, "Cancer diagnosed early often leads to successful treatment. For colorectal cancer, we can even detect and remove adenomas, the precursors to cancer."
Faecal Samples: A Powerful Tool
The study found that both screening methods led to more early-stage cancer detections, especially in the first two years. However, the most remarkable results were seen in the group that underwent FITs. At the end of the follow-up period, only 0.61% of this group developed colorectal cancer, compared to 0.73% in the control group.
Anna Forsberg, a docent at Karolinska Institutet's Department of Medicine, Solna, and the last author of the study, highlights, "Our findings suggest a potential preventive effect of FIT screening. By detecting and removing cancer precursors, we may be able to reduce the incidence of advanced cancer."
Long-Term Effects and Mortality
The researchers also investigated the potential negative effects of increased colonoscopies. While they noticed a slight increase in gastrointestinal bleeding and blood clots, especially in the first year, these events were rare, and the all-cause mortality rate remained the same across all groups.
The participants will continue to be followed until 2030 to assess the long-term effectiveness of these screening methods in reducing colorectal cancer mortality. Forsberg expresses optimism, "We believe that in about five years, when the study is fully evaluated, we will see a significant reduction in mortality from colorectal cancer in both intervention groups."
A National Screening Program
In Sweden, a national screening program for colorectal cancer has been gradually implemented since 2021, with full implementation planned for 2026. This program offers a faecal immunochemical test (FIT) every two years to individuals aged 60-74, followed by a colonoscopy if the sample is positive.
The study SCREESCO, which compares no intervention with different screening methods, has set the foundation for this national program. With its low cutoff values for a positive FIT, it aims to detect cancer precursors early and potentially save lives.
This study not only provides hope for those at risk of colorectal cancer but also opens a discussion on the balance between the benefits of early detection and potential risks. What are your thoughts on the potential impact of these screening methods? Do you think the benefits outweigh the risks? Feel free to share your opinions and insights in the comments below!
